639 reports of this reaction
3.7% of all PYRAZINAMIDE reports
#2 most reported adverse reaction
DRUG INDUCED LIVER INJURY is the #2 most commonly reported adverse reaction for PYRAZINAMIDE, manufactured by ANI Pharmaceuticals, Inc.. There are 639 FDA adverse event reports linking PYRAZINAMIDE to DRUG INDUCED LIVER INJURY. This represents approximately 3.7% of all 17,268 adverse event reports for this drug.
Patients taking PYRAZINAMIDE who experience drug induced liver injury should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INDUCED LIVER INJURY is moderately reported among PYRAZINAMIDE users, representing a notable but not dominant share of adverse events.
In addition to drug induced liver injury, the following adverse reactions have been reported for PYRAZINAMIDE:
The following drugs have also been linked to drug induced liver injury in FDA adverse event reports:
DRUG INDUCED LIVER INJURY has been reported as an adverse event in 639 FDA reports for PYRAZINAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INDUCED LIVER INJURY accounts for approximately 3.7% of all adverse event reports for PYRAZINAMIDE, making it one of the most commonly reported side effect.
If you experience drug induced liver injury while taking PYRAZINAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.